High Energy Density Silicon Anode Li-ion Batteries

Contracts Secured for Silicon Anode Cell Production

Through new manufacturing partnerships, Amprius Technologies is increasing the production capacity of its next-generation Silicon Anode Platform, SiCore, to more than 500MWh By Abi Wylie / 24 Jun 2024
Contracts Secured for Silicon Anode Cell Production
Follow UST

Amprius Technologies has launched a strategic initiative to rapidly increase the global production capacity of its SiCoreTM offering through new manufacturing partnerships. 

Amprius, a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, has signed agreements with several contract manufacturers to secure over 500 MWh of production capacity for its SiCore battery and is engaging with potential additional partners across a network of established Asia-based contract manufacturers.

Since announcing the SiCore platform in January, customers’ demand for large quantities of cells has increased, necessitating the acceleration of SiCore production. The strategic agreements will supply SiCore pouches in various chemistries and form factors, including 18650 and 21700 cylindrical cells.

The flexible capacity allows Amprius to quickly scale up or down production volumes in response to market demand without delays or significant costs. The contract manufacturing partnerships are structured to secure timely and efficient delivery, with stringent quality control measures so every SiCore battery meets our high standards of performance and reliability. 

Multiple manufacturing partners also helps mitigate risks from potential production delays, equipment failures, and supply chain disruptions.

The SiCore product family complements Amprius’ industry-leading SiMaxx TM product line. By leveraging Amprius’ innovative silicon anode cell technology, the SiCore cell family offers versatility that is unparalleled in commercially available batteries, featuring a cell with up to a 50% increase in energy density for extended range and a cell with over 1,200 cycles for exceptional longevity.

Dr. Kang Sun, CEO of Amprius Technologies, said, “Ensuring timely delivery of our cells while maintaining high quality is crucial to our growth. Through these manufacturing partnerships, we expect to achieve the flexibility to scale rapidly, maintain competitive pricing, and meet the diverse needs of our customers. 

“Partnering with established companies eliminates upfront capital expenditures and ensures immediate availability to accelerate our customers’ qualification process and move them into production.”

To learn more, contact Amprius Technologies: Visit Website Send Message View Supplier Profile
Posted by Abi Wylie Connect & Contact
More from Amprius Technologies